Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more →
Incyte's $750M buyout rocked by pause on key trial, asset cull Read more →
Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more →
Talent to power Life Sciences
Tech talent for Life Sciences
« All Events
Actively seeking further engagement from the commercial sector, as well as more broadly from other aspects of the North’s public sector bodies – the more voices we have to promote our sector, the more likely we will be heard.